Prednisone Recruiting Phase 2 Trials for Lung Cancer Small Cell Lung Cancer (SCLC) / advanced thymic carcinoma / Lung Cancers / Pleural Mesotheliomas / Lung Cancer Non-Small Cell Cancer (NSCLC) / Lung Cancer Metastatic Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02496585Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis